Memorial Sloan Kettering medical oncologist and Lymphoma Service Chief Anas Younes

Meet Medical Oncologist Anas Younes

WATCH VIDEO 01:19

Anas Younes, MD

Medical Oncologist

Titles

Chief, Lymphoma Service; Steven Greenberg Chair at Memorial Sloan Kettering

Clinical Expertise

Hodgkin and Non-Hodgkin Lymphomas; New Targeted Therapies

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Younes accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me

Education

MD, University of Damascus School of Medicine

Residencies

Pathology - Medical College of Ohio; Internal Medicine - SUNY Downstate Medical Center

Fellowships

Hematology/Oncology - Memorial Sloan Kettering Cancer Center

Board Certifications

Internal Medicine; Medical Oncology

I am a medical oncologist and Chief of Memorial Sloan Kettering’s Lymphoma Service. I work with 16 world-class lymphoma experts who are devoted to caring for people with all types of Hodgkin lymphoma and non-Hodgkin lymphoma. We collaborate closely with our colleagues across MSK to provide personalized, comprehensive care for each of our patients. Our clinical trials research program is leading the way in discovering new treatment options that are improving outcomes and quality of life for people with lymphoma. These include immunotherapies, targeted therapies, and combination therapies.

I joined MSK in 2013 with two decades of experience in treating and managing people with lymphoma at MD Anderson Cancer Center in Houston. I also have an extensive background in translational scientific research, which means that I use findings in my lab to fuel the discovery of new therapies and treatment strategies. I am particularly interested in developing novel targeted therapies and linking them to biomarkers that can help match people with the most effective and least toxic medicines.

I have served as the principal investigator of numerous clinical trials in people with Hodgkin and non-Hodgkin lymphoma, including national and international multi-center studies. I have led the efforts to develop the first FDA-approved targeted drug for the treatment of Hodgkin lymphoma in more than three decades (brentuximab vedotin, or Adcetris®), and most recently the approval of the first immune checkpoint inhibitor for lymphoma (nivolumab, or Opdivo®).

I have led a National Cancer Institute–funded Specialized Programs of Research Excellence in lymphoma focused on developing novel treatment strategies for Hodgkin and non-Hodgkin lymphoma, both at MD Anderson and MSK.

I am also leading a Specialized Center of Research collaborative grant funded by the Leukemia & Lymphoma Society and focused on the development of immune therapy for lymphoma. I serve on the Scientific Advisory Board of the Lymphoma Research Foundation and am a past member of the National Cancer Institute Lymphoma Steering Committee. When people with lymphoma come to MSK for their care, they can feel reassured that from the moment they walk through the door, they will have an entire team of experts committed to their care.

I actively post on social media about clinical trials, scientific publications, and medical advances. You can follow me on Twitter and like my page on Facebook to stay connected.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

Clinical Trials

Smiling doctors in the lab

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Research and Publications

View Dr. Younes's Lab

Publications on PubMed

Visit PubMed for a full listing of Dr. Younes’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.